David J Stewart

David J Stewart

UNVERIFIED PROFILE

Are you David J Stewart?   Register this Author

Register author
David J Stewart

David J Stewart

Publications by authors named "David J Stewart"

Are you David J Stewart?   Register this Author

100Publications

1717Reads

42Profile Views

Photophysical properties of organogold(i) complexes bearing a benzothiazole-2,7-fluorenyl moiety: selection of ancillary ligand influences white light emission.

Dalton Trans 2019 Sep 10. Epub 2019 Sep 10.

Department of Chemistry, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio 44106, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c9dt02312gDOI Listing
September 2019

Potential Life-Years Lost: The Impact of the Cancer Drug Regulatory and Funding Process in Canada.

Oncologist 2019 Sep 10. Epub 2019 Sep 10.

Division of Medical Oncology, Department of Medicine, The Ottawa Hospital Cancer Centre and the University of Ottawa, Ottawa, Ontario, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2019-0314DOI Listing
September 2019

Optimal frequency of scans for patients on cancer therapies: A population kinetics assessment.

Cancer Med 2019 Sep 27. Epub 2019 Sep 27.

University of Ottawa, Ottawa, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.2571DOI Listing
September 2019

From Dipyrrolonaphthyridinediones to Quinazolinoindolizinoindolizinoquinazolines.

J Org Chem 2019 Jun 7. Epub 2019 Jun 7.

Institute of Organic Chemistry , Polish Academy of Sciences , Kasprzaka 44/52 , 01-224 Warsaw , Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.joc.9b00839DOI Listing
June 2019

A prospective intervention to improve happiness and reduce burnout in oncologists.

Support Care Cancer 2019 Apr 30;27(4):1563-1572. Epub 2018 Nov 30.

Division of Medical Oncology, Department of Oncology, University of Alberta, Cross Cancer Institute, Edmonton, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4567-5DOI Listing
April 2019

Manipulating triplet states: tuning energies, absorption, lifetimes, and annihilation rates in anthanthrene derivatives.

Phys Chem Chem Phys 2018 Nov;20(45):28412-28418

Air Force Research Laboratory, Materials and Manufacturing Directorate, Functional Materials Division, Wright-Patterson AFB, Ohio 45433-7750, USA.

View Article

Download full-text PDF

Source
http://xlink.rsc.org/?DOI=C8CP06048G
Publisher Site
http://dx.doi.org/10.1039/c8cp06048gDOI Listing
November 2018

Effects of intramolecular hydrogen bonding and sterically forced non-coplanarity on organic donor/acceptor two-photon-absorbing molecules.

Phys Chem Chem Phys 2018 Jul;20(29):19398-19407

Air Force Research Laboratory, Materials and Manufacturing Directorate, Functional Materials Division, Wright-Patterson AFB, Ohio 45433-7750, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c8cp02647eDOI Listing
July 2018

Photodriven Oxygen Removal via Chromophore-Mediated Singlet Oxygen Sensitization and Chemical Capture.

Inorg Chem 2017 Aug 11;56(15):9273-9280. Epub 2017 Jul 11.

U.S. Army Research Laboratory , 2800 Powder Mill Road, Adelphi, Maryland 20783-1138, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.inorgchem.7b01226DOI Listing
August 2017

Effect of steroid and serum starvation on a human breast cancer adenocarcinoma cell line.

J Exp Ther Oncol 2017 May;12(1):25-34

Department of Toxico/Pharmacology, School of Pharmacy, Shahid Beheshti Medical University, Tehran, Iran.

View Article

Download full-text PDF

Source
May 2017

Exploring the Benefit/Risk Associated with Antiangiogenic Agents for the Treatment of Non-Small Cell Lung Cancer Patients.

Clin Cancer Res 2017 Mar 9;23(5):1137-1148. Epub 2016 Dec 9.

Division of Medical Oncology, University of Ottawa, Ottawa, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-1968DOI Listing
March 2017

Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non-Small Cell Lung Carcinoma Cells.

Neoplasia 2016 09;18(9):525-35

Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Faculty of Medicine, Department of Biochemistry, Microbiology and Immunology, Ottawa, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neo.2016.07.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031866PMC
September 2016

Insurance Denial of Coverage for Patients Enrolled in Cancer Clinical Trials Is Still a Problem in the Affordable Care Act Era.

J Oncol Pract 2016 Apr 23;12(4):283-5. Epub 2016 Feb 23.

MD Anderson Cancer Center, Houston, TX; Dana-Farber Cancer Institute, Boston, MA; and University of Ottawa, Ottawa, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2015.010454DOI Listing
April 2016

Steric hindrance inhibits excited-state relaxation and lowers the extent of intramolecular charge transfer in two-photon absorbing dyes.

Phys Chem Chem Phys 2016 Feb 1;18(7):5587-96. Epub 2016 Feb 1.

Air Force Research Laboratory, Materials and Manufacturing Directorate, Functional Materials Division, Wright-Patterson AFB, Ohio 45433-7750, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c5cp07716hDOI Listing
February 2016

Click chemistry, 3D-printing, and omics: the future of drug development.

Oncotarget 2016 Jan;7(3):2155-8

Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.6787DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823025PMC
January 2016

miR Profiling Identifies Cyclin-Dependent Kinase 6 Downregulation as a Potential Mechanism of Acquired Cisplatin Resistance in Non-Small-Cell Lung Carcinoma.

Clin Lung Cancer 2015 Nov 3;16(6):e121-9. Epub 2015 Feb 3.

Centre for Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Department of Biochemistry, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2015.01.008DOI Listing
November 2015

The Urgent Need for Clinical Research Reform to Permit Faster, Less Expensive Access to New Therapies for Lethal Diseases.

Clin Cancer Res 2015 Oct;21(20):4561-8

University of California San Diego Moores Cancer Center, San Diego, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-3246DOI Listing
October 2015

Redefining cancer: a new paradigm for better and faster treatment innovation.

J Popul Ther Clin Pharmacol 2014 23;21(1):e56-65. Epub 2014 Feb 23.

View Article

Download full-text PDF

Source
July 2015

Organic component vapor pressures and hygroscopicities of aqueous aerosol measured by optical tweezers.

J Phys Chem A 2015 Jan 15;119(4):704-18. Epub 2015 Jan 15.

The Institute of Chemical Physics, Key Laboratory of Cluster Science, Beijing Institute of Technology , Beijing 100081, People's Republic of China.

View Article

Download full-text PDF

Source
http://pubs.acs.org/doi/10.1021/jp510525r
Publisher Site
http://dx.doi.org/10.1021/jp510525rDOI Listing
January 2015

Rigid medium effects on photophysical properties of MLCT excited states of polypyridyl Os(II) complexes in polymerized poly(ethylene glycol)dimethacrylate monoliths.

J Phys Chem A 2014 Nov 30;118(45):10326-32. Epub 2014 Apr 30.

Department of Chemistry, The University of North Carolina at Chapel Hill , Chapel Hill, North Carolina 27599, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jp5019873DOI Listing
November 2014

An analytical framework for delirium research in palliative care settings: integrated epidemiologic, clinician-researcher, and knowledge user perspectives.

J Pain Symptom Manage 2014 Aug 12;48(2):159-175. Epub 2014 Apr 12.

Division of Palliative Care (P.G.L.), Department of Medicine, Epidemiology and Community Medicine, University of Ottawa; Bruyère Research Institute (P.G.L., S.H.B.), Bruyère Continuing Care; The Ottawa Hospital Research Institute (P.G.L., S.K.), Ottawa, Ontario, Canada; Institute of Public Health (D.H.J.D.), University of Cambridge, Cambridge, United Kingdom; Knowledge Synthesis Group (M.An.), Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Faculty of Nursing (A.H.), University of Notre Dame, Sydney, New South Wales, Australia; The Ottawa Hospital (S.K.); Clinical Epidemiology Program (F.M.), Ottawa Hospital Research Institute; Children's Hospital of Eastern Ontario Research Institute (F.M.), University of Ottawa; Division of Palliative Care (S.H.B.), Department of Medicine, University of Ottawa, Ottawa, Ontario; Department of Symptom Control and Palliative Care (S.W.), Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada; Discipline of Palliative and Supportive Services (D.C.C., M.Ag.), Flinders University, Adelaide, South Australia, Australia; Département de médecine familiale et de médecine d'urgence (B.G.), Université Laval; Centre de recherche du CHU de Québec (B.G.), Québec City, Québec, Canada; South West Sydney Clinical School (M.Ag.), University of New South Wales; Department of Palliative Care (M.Ag.), Braeside Hospital, Hammond Care, Sydney, New South Wales, Australia; The University of Texas M. D. Anderson Cancer Center (E.B.), Houston, Texas, USA; Graduate Entry Medical School (D.J.M.), University of Limerick, Limerick, Ireland; Academic Medical Centre (S.E.J.A.d.R.), University of Amsterdam, Amsterdam, The Netherlands; Research and Academic Institute of Athens (D.A.), Athens, Greece; Palliative Care, Pain Therapy and Rehabilitation Unit (A.C.), Fondazione IRCCS, Istituto Nazionale Dei Tumori, Milan, Italy; Department of Palliative Care (K.M.), Bruyère Continuing Care; and Department of Medical Oncology (D.J.S.), The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08853924140015
Publisher Site
http://dx.doi.org/10.1016/j.jpainsymman.2013.12.245DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128755PMC
August 2014

Response.

Authors:
David J Stewart

J Natl Cancer Inst 2014 Aug 31;106(8). Epub 2014 Jul 31.

Division of Medical Oncology, University of Ottawa, 501 Smyth Road, Ottawa, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju190DOI Listing
August 2014

U.S. Food and Drug Administration inspections of clinical investigators: overview of results from 1977 to 2009.

Clin Cancer Res 2014 Jul 15;20(13):3364-70. Epub 2014 Apr 15.

Center for Personalized Cancer Therapy, Moores Cancer Center, University of California San Diego, San Diego, California; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-3206DOI Listing
July 2014

Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer.

Lung Cancer 2014 Jul 22;85(1):88-93. Epub 2014 Apr 22.

Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.04.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090351PMC
July 2014

Symmetry- and solvent-dependent photophysics of fluorenes containing donor and acceptor groups.

J Phys Chem A 2014 Jul 7;118(28):5228-37. Epub 2014 Jul 7.

Air Force Research Laboratory, Materials and Manufacturing Directorate, Functional Materials Division, Wright-Patterson AFB , Dayton, Ohio 45433-7750, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jp504319uDOI Listing
July 2014

Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancer.

J Thorac Oncol 2014 May;9(5):675-84

*Division of Medical Oncology, University of Ottawa, Ottawa, Ontario, Canada; and Departments of †Pathiology, ‡Biostatistics, §Thoracic and Cardiovascular Surgery, ||Thoracic/Head and Neck Medical Oncology, and ¶Translational Molecular Pathology, University of Texas M. D. Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084898PMC
May 2014

Wnt signaling pathway in non-small cell lung cancer.

Authors:
David J Stewart

J Natl Cancer Inst 2014 Jan 5;106(1):djt356. Epub 2013 Dec 5.

Affiliation of author: Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt356DOI Listing
January 2014

A cancer trial scandal and its regulatory backlash.

Nat Biotechnol 2014 Jan;32(1):27-31

Division of Medical Oncology, The University of Ottawa, Ottawa, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nbt.2792DOI Listing
January 2014

EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma.

Clin Cancer Res 2013 Dec 4;19(23):6556-65. Epub 2013 Oct 4.

Authors' Affiliations: Departments of Thoracic/Head and Neck Medical Oncology, Pathology, Biostatistics, Thoracic Surgery, and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and The University of Ottawa, Ottawa, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-3946DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890101PMC
December 2013

Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trial.

Clin Cancer Res 2013 Dec 28;19(24):6967-75. Epub 2013 Oct 28.

Authors' Affiliations: Departments of Thoracic/Head and Neck Medical Oncology, Biostatistics and Applied Mathematics, Translational Molecular Pathology, Diagnostic Imaging, Diagnostic Radiology, and Bioinformatics and Computational Biology; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston; The Hamon Center for Therapeutic Oncology Research and Departments of Internal Medicine and Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas; Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Charlotte, North Carolina; Medical Oncology, Yale Cancer Center, New Haven, Connecticut; Division of Medical Oncology, University of Ottawa, Ottawa, Ontario; Department of Oncology and Diagnostic Sciences, University of Maryland Dental School, Baltimore, Maryland; UC San Diego Moores Cancer Center, La Jolla, California; and Centre de Recherche en Cancérologie de Lyon, UMR INSERM 1052-CNRS 5286, Centre Léon Bérard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-1818DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905243PMC
December 2013

Cancer research in the United States: dying by a thousand paper cuts.

Cancer 2013 Nov 6;119(21):3742-5. Epub 2013 Jun 6.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28193DOI Listing
November 2013

Varying substituents and solvents to maximize the luminescence from [Ru(trpy)(bpy)CN]+ derivatives.

Inorg Chem 2013 Nov 15;52(21):12553-60. Epub 2013 Oct 15.

Department of Chemistry, Purdue University , 560 Oval Drive, West Lafayette, Indiana 47907-2084, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/ic4016367DOI Listing
November 2013

Compliance in early-phase cancer clinical trials research.

Oncologist 2013 1;18(3):308-13. Epub 2013 Mar 1.

Division of Hematology-Oncology, University of California, San Diego, Moores Cancer Center, San Diego, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2012-0260DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607528PMC
September 2013

Exciplex formation in blended spin-cast films of fluorene-linked dyes and bisphthalimide quenchers.

J Phys Chem A 2013 May 1;117(19):3909-17. Epub 2013 May 1.

Functional Materials Division, Materials and Manufacturing Directorate, Air Force Research Laboratory, Wright-Patterson AFB, Ohio 45433-7750, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jp312029eDOI Listing
May 2013

Nuclear war between Israel and Iran: lethality beyond the pale.

Confl Health 2013 May 10;7(1):10. Epub 2013 May 10.

Institute for Disaster Management, College of Public Health, 001 Barrow Hall, Athens GA 30633, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1752-1505-7-10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671126PMC
May 2013

Fool's gold, lost treasures, and the randomized clinical trial.

BMC Cancer 2013 Apr 16;13:193. Epub 2013 Apr 16.

Division of Medical Oncology, The University of Ottawa, Ottawa, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-13-193DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639810PMC
April 2013

Can EGFR mutation status evolve with chemotherapy?

Chin Clin Oncol 2013 Mar;2(1)

James P. Wilmot Cancer Center, and the Department of Medicine, University of Rochester, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2012.11.09DOI Listing
March 2013

Excited-state dynamics in rigid media: evidence for long-range energy transfer.

J Phys Chem B 2013 Mar 19;117(12):3428-38. Epub 2013 Mar 19.

Department of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jp400514rDOI Listing
March 2013

Non-small-cell lung cancer with HER2 exon 20 mutation: regression with dual HER2 inhibition and anti-VEGF combination treatment.

J Thorac Oncol 2013 Feb;8(2):e19-20

Department of Investigational Cancer Therapeutics (phase I Clinical Trials Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153275
Publisher Site
http://dx.doi.org/10.1097/JTO.0b013e31827ce38eDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551245PMC
February 2013

Accelerating slow excited state proton transfer.

Proc Natl Acad Sci U S A 2013 Jan 31;110(3):876-80. Epub 2012 Dec 31.

Department of Chemistry, University of North Carolina, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1220742110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549109PMC
January 2013

Plasma biomarkers correlating with clinical outcome in a phase II study of sorafenib in advanced NSCLC.

Cancer Biomark 2011-2012;10(6):287-98

University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/CBM-2012-0253DOI Listing
November 2012

Outcomes of phase II clinical trials with single-agent therapies in advanced/metastatic non-small cell lung cancer published between 2000 and 2009.

Clin Cancer Res 2012 Nov 26;18(22):6356-63. Epub 2012 Sep 26.

Department of Investigational Cancer Therapeutics, Phase I Clinical Trials Program, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-0178DOI Listing
November 2012

Systematic evaluation of apoptotic pathway gene polymorphisms and lung cancer risk.

Carcinogenesis 2012 Sep 4;33(9):1699-706. Epub 2012 Jun 4.

Department of Epidemiology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgs192DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514904PMC
September 2012

Before we throw out progression-free survival as a valid end point...

Authors:
David J Stewart

J Clin Oncol 2012 Sep 23;30(27):3426-7. Epub 2012 Jul 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.44.1220DOI Listing
September 2012

Tissue platinum concentration and tumor response in non-small-cell lung cancer.

J Clin Oncol 2012 Sep 13;30(27):3345-52. Epub 2012 Aug 13.

The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 463, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.40.8120DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438232PMC
September 2012

Sensitization of ultra-long-range excited-state electron transfer by energy transfer in a polymerized film.

Proc Natl Acad Sci U S A 2012 Sep 4;109(38):15132-5. Epub 2012 Sep 4.

Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1213646109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458388PMC
September 2012

An amide-linked chromophore-catalyst assembly for water oxidation.

Inorg Chem 2012 Jun 1;51(12):6428-30. Epub 2012 Jun 1.

Department of Chemistry, University of North Carolina at Chapel Hill, CB 3290, Chapel Hill, North Carolina 27599-3290, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/ic300061uDOI Listing
June 2012

Kinase-impaired BRAF mutations in lung cancer confer sensitivity to dasatinib.

Sci Transl Med 2012 May;4(136):136ra70

Department of Thoracic/Head and Neck Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3003513DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836384PMC
May 2012

Novel therapeutic targets in non-small cell lung cancer.

J Thorac Oncol 2011 Sep;6(9):1601-12

Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S155608641531339
Publisher Site
http://dx.doi.org/10.1097/JTO.0b013e31822944b3DOI Listing
September 2011

Chemotherapy dose intensity and survival in non-small cell lung cancer.

Authors:
David J Stewart

J Thorac Oncol 2011 May;6(5):971

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318215a39bDOI Listing
May 2011

Sorafenib-induced premalignant and malignant skin lesions.

Int J Dermatol 2011 Apr;50(4):396-402

Baylor College of Medicine, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-4632.2010.04822.xDOI Listing
April 2011

Potential of CXCR4 antagonists for the treatment of metastatic lung cancer.

Expert Rev Anticancer Ther 2011 Apr;11(4):621-30

Department of Leukemia, Unit 428, The University of Texas MD Anderson Cancer Center, PO Box 301402, Houston, TX 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.11.11DOI Listing
April 2011

Antagonism between gefitinib and cisplatin in non-small cell lung cancer cells: why randomized trials failed?

J Thorac Oncol 2011 Mar;6(3):559-68

Section of Thoracic Oncology, Chest Department, Taipei Veterans General Hospital, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3182021ff5DOI Listing
March 2011

Exponential decay nonlinear regression analysis of patient survival curves: preliminary assessment in non-small cell lung cancer.

Lung Cancer 2011 Feb;71(2):217-23

Department of Thoracic/Head & Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2010.05.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962880PMC
February 2011

Translating clinical trials into meaningful outcomes.

Clin Cancer Res 2010 Dec;16(24):5951-5

Karmanos Cancer Institute, Wayne State University, Detroit, Michigan 48201, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2632DOI Listing
December 2010

Randomized phase II trials: misleading and unreliable.

Authors:
David J Stewart

J Clin Oncol 2010 Nov 20;28(31):e649-50; author reply e651-3. Epub 2010 Sep 20.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.31.3254DOI Listing
November 2010

Extensive disease small cell lung cancer dose-response relationships: implications for resistance mechanisms.

J Thorac Oncol 2010 Nov;5(11):1826-34

Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181f387c7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2966343PMC
November 2010

Phase II study of dasatinib in patients with advanced non-small-cell lung cancer.

J Clin Oncol 2010 Oct 20;28(30):4609-15. Epub 2010 Sep 20.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.30.5474DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2974341PMC
October 2010

Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer.

Authors:
David J Stewart

Crit Rev Oncol Hematol 2010 Sep 4;75(3):173-234. Epub 2010 Jan 4.

Department of Thoracic/Head & Neck Medical Oncology, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2009.11.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2888634PMC
September 2010

A red-emitting light switch based on a heteroleptic ruthenium(II) complex containing a tridentate dppz analogue.

Inorg Chem 2010 Aug;49(15):6814-6

Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907-2084, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/ic1010117DOI Listing
August 2010

Targeted therapy in non-small-cell lung cancer--is it becoming a reality?

Nat Rev Clin Oncol 2010 Jul 15;7(7):401-14. Epub 2010 Jun 15.

Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrclinonc.2010.64
Publisher Site
http://dx.doi.org/10.1038/nrclinonc.2010.64DOI Listing
July 2010

Equipoise lost: ethics, costs, and the regulation of cancer clinical research.

J Clin Oncol 2010 Jun 20;28(17):2925-35. Epub 2010 Apr 20.

Department of Thoracic/Head and Neck Medical Oncology, M D Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2009.27.5404
Publisher Site
http://dx.doi.org/10.1200/JCO.2009.27.5404DOI Listing
June 2010

Weekly alternating therapy with irinotecan plus cisplatin and etoposide plus cisplatin in the treatment of patients with extensive small cell lung carcinoma.

Cancer 2010 May;116(10):2409-15

Department of Thoracic Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25076DOI Listing
May 2010

Ultimate fate of oncology drugs approved by the us food and drug administration without a randomized Trial.

J Clin Oncol 2009 Dec 13;27(36):6243-50. Epub 2009 Oct 13.

The University of Texas M. D. Anderson Cancer Center, Department of Investigational Cancer Therapeutics, Unit 455, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2009.23.6018
Publisher Site
http://dx.doi.org/10.1200/JCO.2009.23.6018DOI Listing
December 2009

Phase II, multicenter, uncontrolled trial of single-agent sorafenib in patients with relapsed or refractory, advanced non-small-cell lung cancer.

J Clin Oncol 2009 Sep 3;27(26):4274-80. Epub 2009 Aug 3.

The M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 432, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.22.0541DOI Listing
September 2009

Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases.

Cancer 2009 Jul;115(13):2930-8

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24333DOI Listing
July 2009

CXCR4 chemokine receptor antagonists: perspectives in SCLC.

Expert Opin Investig Drugs 2009 Apr;18(4):481-90

University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543780902804249DOI Listing
April 2009

Cancer: the road to Amiens.

J Clin Oncol 2009 Jan 8;27(3):328-33. Epub 2008 Dec 8.

Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.18.9621DOI Listing
January 2009

Gefitinib maintenance in stage III non-small-cell lung cancer.

Authors:
David J Stewart

J Clin Oncol 2008 Oct 8;26(29):4849-50; author reply 4850-1. Epub 2008 Sep 8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.18.7625DOI Listing
October 2008

Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer.

J Thorac Oncol 2008 Apr;3(4):351-7

Department of Diagnostic Imaging, University of Texas, M. D. Anderson Cancer Center, Sheba Medical Center, Tel Hashomer, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318168c7e9DOI Listing
April 2008

Kinetics and mechanisms of chlorine dioxide oxidation of tryptophan.

Inorg Chem 2008 Mar 7;47(5):1639-47. Epub 2008 Feb 7.

Department of Chemistry, Purdue University, West Lafayette, Indiana 47907-2084, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/ic701761pDOI Listing
March 2008

Systemic therapy for lung cancer brain metastases: a rationale for clinical trials.

Oncology (Williston Park) 2008 Feb;22(2):168-78; discussion 178, 183, 188 passim

Department of Thoracic, Head & Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
February 2008

Genetic variants in cell cycle control pathway confer susceptibility to lung cancer.

Clin Cancer Res 2007 Oct;13(19):5974-81

Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-0113DOI Listing
October 2007

Phase I trial of motexafin gadolinium in combination with docetaxel and cisplatin for the treatment of non-small cell lung cancer.

J Thorac Oncol 2007 Aug;2(8):745-50

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S155608641531305
Publisher Site
http://dx.doi.org/10.1097/JTO.0b013e31811f4719DOI Listing
August 2007

Deficient G2-M and S checkpoints are associated with increased lung cancer risk: a case-control analysis.

Cancer Epidemiol Biomarkers Prev 2007 Jul;16(7):1517-22

Department of Epidemiology, Unit 1340, The University of Texas M. D. Anderson Cancer Center, 1155 Pressler Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://cebp.aacrjournals.org/cgi/doi/10.1158/1055-9965.EPI-0
Publisher Site
http://dx.doi.org/10.1158/1055-9965.EPI-07-0111DOI Listing
July 2007